By Chris Taylor NEW YORK (Reuters) – For generations, society has grappled with the question of whether money brings happiness.…
Nearly 60 hair relaxer lawsuits against L’Oreal, others consolidated in Illinois federal court
By Diana Novak Jones (Reuters) – Nearly 60 lawsuits claiming hair relaxer products sold by L’Oreal USA Inc and other…
Drug companies face COVID cliff in 2023 as sales set to plummet
By Michael Erman and Patrick Wingrove NEW YORK (Reuters) – Pharmaceutical companies that made billions from the pandemic over the…
U.S. military members suing 3M seek dismissal of subsidiary’s bankruptcy
By Dietrich Knauth (Reuters) – Current and former U.S. military members suing 3M over allegedly defective military earplugs have asked…
Cigna expects revenue gains from launches of Humira biosimilars
By Leroy Leo (Reuters) -Cigna Corp expects its pharmacy benefit management unit to earn more from the second half of…
Regeneron profit beats estimates on Dupixent strength
(Reuters) -Regeneron Pharmaceuticals Inc reported a better-than-expected fourth-quarter profit on Friday, as strong demand for eczema drug Dupixent helped shield a…
Gilead profit beats Street expectations on COVID and HIV sales
By Michael Erman and Sriparna Roy (Reuters) -Gilead Sciences Inc on Thursday reported a higher-than-expected fourth-quarter profit driven by strong…
USTR seeks public comment on restoring tariffs on Chinese medical products
By David Lawder WASHINGTON (Reuters) – The U.S. Trade Representative’s Office said on Thursday it is seeking public comment on…
Eli Lilly’s weak diabetes drugs sales cloud 2023 profit forecast
By Bhanvi Satija and Patrick Wingrove (Reuters) -Eli Lilly and Co missed Wall Street estimates for fourth-quarter sales of both…
Bank of England hints rates near peak after 10th hike
By William Schomberg and David Milliken LONDON (Reuters) – The Bank of England signalled the tide was turning in its…